Literature DB >> 20016915

Purpura fulminans in a newborn infant with galactosemia.

Aysegul Zenciroglu1, Mehmet Sah Ipek, Mustafa Aydin, Abdurrahman Kara, Nurullah Okumus, Mustafa Kilic.   

Abstract

An 11-day-old neonate presented with purpura fulminans and was subsequently diagnosed with galactosemia. Neonatal purpura fulminans occurs predominantly in patients suffering from inherited protein C deficiency or disseminated intravascular coagulation associated with septicemia. Hemostatic changes in patients with liver disease may result in bleeding or, rarely, thrombosis. We suppose that in the present patient, deficiency of protein C, secondary to liver disease, was responsible for the development of purpura fulminans. Treatment consisted of blood and blood products and galactose-free formula. The patient recovered with residual mild psychomotor retardation and the lesions with minimal scarring. In conclusion, galactosemia also should be kept in mind as an uncommon cause of purpura fulminans in newborn infants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016915     DOI: 10.1007/s00431-009-1121-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Neonatal purpura fulminans and transient protein C deficiency.

Authors:  C Minutillo; P J Pemberton; M L Willoughby; P J Price; L R Marshall
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

Review 2.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

3.  Outcome in children with purpura fulminans: report on 16 patients.

Authors:  Aytemiz Gürgey; Selin Aytac; Guler Kanra; Gulten Secmeer; Mehmet Ceyhan; Cigdem Altay
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

Review 4.  Coagulation disorders in liver disease.

Authors:  Lucio Amitrano; Maria A Guardascione; Vincenzo Brancaccio; Antonio Balzano
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

5.  Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Authors:  M Levi; C H Toh; J Thachil; H G Watson
Journal:  Br J Haematol       Date:  2009-02-12       Impact factor: 6.998

Review 6.  Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.

Authors:  Ton Lisman; Frank W G Leebeek
Journal:  Dig Surg       Date:  2007-07-27       Impact factor: 2.588

Review 7.  Acute infectious purpura fulminans: pathogenesis and medical management.

Authors:  G L Darmstadt
Journal:  Pediatr Dermatol       Date:  1998 May-Jun       Impact factor: 1.588

8.  Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies.

Authors:  J G Ray; D Shmorgun; W S Chan
Journal:  Pathophysiol Haemost Thromb       Date:  2002 Mar-Apr

Review 9.  Hypercoagulation and thrombophilia in liver disease.

Authors:  P G Northup; V Sundaram; M B Fallon; K R Reddy; R A Balogun; A J Sanyal; Q M Anstee; M R Hoffman; Y Ikura; S H Caldwell
Journal:  J Thromb Haemost       Date:  2007-09-24       Impact factor: 5.824

Review 10.  Thrombosis in the critically ill neonate: incidence, diagnosis, and management.

Authors:  Alex Veldman; Marcel F Nold; Ina Michel-Behnke
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  1 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.